Post-Traumatic Stress Disorder
Post-Traumatic Stress Disorder (PTSD) is a mental and behavioral disorder that develops after experiencing a traumatic event, manifesting through symptoms such as intrusive thoughts, flashbacks, sleep disturbances, avoidance behaviors, and emotional or physical dysregulation. These symptoms, which can appear immediately or years later, persist for over a month and increase the risk of suicide and self-harm.
Health Outcomes
- Activation of Stress Response Pathways
- Alleviated Depression
- Altered Brain Activity to Negative Emotional Stimuli
- Altered Catecholamine Level
- Altered Endocannabinoid System Function Due to Specific Strain
- Altered Neurobiological Markers
- Changed Autonomic Nervous System Activity
- Elevated Pulse Rate Under Stress
- Enhanced Autonomic Function
- Enhanced Autonomic Nervous System Activity
- Enhanced Parasympathetic Nervous System Activity
- Enhanced Serotonin Pathway Function
- Enhanced Stress Resistance
- Enhanced Threat Response Appropriateness
- Improved Antidepressant Response
- Improved Anxiety Symptoms
- Improved Autonomic Nervous System Activity
- Improved Behavioral Elements
- Improved Behavioral Health
- Improved Coping Strategies
- Improved Depressive Symptoms
- Improved Distress of Life Score
- Improved Emotional Behavior
- Improved Emotional Dysregulation
- Improved Emotional Function
- Improved Emotional Functioning
- Improved Emotional Processing
- Improved Emotional State
- Improved Emotional Well-Being Quality of Life
- Improved Emotional Well-being
- Improved Emotional and Behavioral Changes
- Improved Enjoyment of Life
- Improved General Behavioral Scores
- Improved Global Assessment of Efficacy
- Improved Global Clinical Impression
- Improved Global Improvement of Symptoms (Clinician-Rated)
- Improved Global Symptom Score
- Improved Glucocorticoid Negative Feedback on the HPA Axis
- Improved HPA Axis Response
- Improved Heart Rate Variability
- Improved High-Frequency Power
- Improved Inhibitory Control
- Improved Mental Health
- Improved Mood Disturbance
- Improved Neuroendocrine Stress Markers
- Improved Neuropsychiatric Outcomes
- Improved Parasympathetic Activity
- Improved Patient Global Impression of Improvement
- Improved Perceived Mental Well-being
- Improved Positive Mood States
- Improved Positive Well-Being
- Improved Psychological Distress
- Improved Psychological Function
- Improved Psychological Status
- Improved Psychological Well-being
- Improved Psychosocial Domain Score
- Improved Psychosocial Health-Related Quality of Life
- Improved Regulation of HPA Axis
- Improved Relaxation
- Improved Role Emotional
- Improved Serotonin Metabolism
- Improved Sex Life
- Improved Significant Response Rate
- Improved Sleep-Related Recovery in Participants with High Chronic Stress
- Improved Socialization
- Improved Stress Management
- Improved Stress Resilience
- Improved Stress Response
- Improved Stress Tolerance
- Improved Stress-Related Psychiatric Health
- Improved Subjective Recovery
- Improved Sympathetic Tone
- Improved Temperament
- Improved Vigor
- Improved Willingness to Continue Treatment
- Increased Anger/Hostility
- Increased Arousal
- Increased Attachment Gain
- Increased BDNF Levels in the Prefrontal Cortex
- Increased Cortisol Levels
- Increased Heart Rate Response to Stress
- Increased Hypocapnic Hyperventilation Area Time
- Increased Insomnia
- Increased Irritability
- Increased Oxytocin Synthesis in the Hypothalamus
- Increased Salivary Oxytocin Level
- Increased Serum BDNF Levels
- Increased Serum Serotonin Levels
- Increased Social Avoidance
- Increased Stress Biomarkers
- Increased Systemic GABA Levels
- Increased Treatment Responders
- Maintained Lower Salivary Cortisol Levels
- Maintained Positive Mood Under Stress
- Modulated HPA Axis
- No CYP1A2 or CYP3A4 Interaction
- No Change in Appetite Parameters
- No Reduction in Stress or Anxiety
- Normalized Cortisol Levels
- Normalized HPA Axis Activity
- Normalized Stress Response
- Reduced 5-Hydroxytryptamine Level
- Reduced ADAM Symptomatology Score
- Reduced Abnormal Brain Plasticity Due to Stress
- Reduced Aggressive Feeling
- Reduced Agitation
- Reduced Anger
- Reduced Anhedonia
- Reduced Anxiety
- Reduced Anxiety Responses
- Reduced Anxiety Scores
- Reduced Anxiety Symptom
- Reduced Anxiety Symptoms
- Reduced Anxiety-Related Biomarkers
- Reduced Anxiety-Related Physiological Changes
- Reduced Anxiety-like Behavior
- Reduced Clinically Relevant Anxiety
- Reduced Corticosterone Levels
- Reduced Cortisol Levels
- Reduced DASS-21 Score
- Reduced Depression Anxiety Stress Symptoms
- Reduced Depression Scores at Follow-Up
- Reduced Depression and Anxiety Scores
- Reduced Distress Symptoms
- Reduced Disturbed Sleep Night
- Reduced Emotional Fatigue
- Reduced Fear
- Reduced Fecal Cortisol Levels
- Reduced General Psychopathology
- Reduced General Psychopathology Score
- Reduced Global Symptoms
- Reduced Gut Bacteria Associated with Mental Illness
- Reduced HPA Axis Hyperactivity
- Reduced Heart Rate Variability
- Reduced Hippocampal Apoptosis
- Reduced Hyperactivity of the Hypothalamic-Pituitary-Adrenal Axis
- Reduced Incidence of Crying
- Reduced Irritability
- Reduced Limbic System Reactivity
- Reduced Mental Health Symptom
- Reduced Negative Emotional Responses
- Reduced Negative Mood States
- Reduced Neuropeptide Y Level
- Reduced Occurrence of Major Depressive Disorder
- Reduced PTSD Severity
- Reduced Perceived Stress
- Reduced Post-Concussion Symptom
- Reduced Post-Exercise Cortisol Response
- Reduced Psychiatric Problems
- Reduced Psychiatric Symptom
- Reduced Psychiatric Symptom Severity
- Reduced Psychological Distress
- Reduced Psychological Score
- Reduced Psychopathology Symptoms
- Reduced Psychosocial Symptom
- Reduced Relapse
- Reduced Salivary Alpha-Amylase Activity
- Reduced Salivary Chromogranin A Levels
- Reduced Salivary Cortisol Levels Under Stress
- Reduced Salivary Serotonin Levels in Response to Stress
- Reduced Serum BDNF Levels
- Reduced Serum Cortisol Levels
- Reduced Sleep Duration
- Reduced Somatic Symptom
- Reduced Stress Biomarkers
- Reduced Stress Hormone Levels
- Reduced Stress Indicators
- Reduced Stress Level
- Reduced Stress Levels
- Reduced Stress Markers
- Reduced Stress Response
- Reduced Stress Scores
- Reduced Stress-Induced Anxiety
- Reduced Stress-Induced Hyperpermeability
- Reduced Stress-Induced Reduction in Diurnal Temperature Amplitude
- Reduced Stress-Induced Sleep Disruption
- Reduced Stress-Related Discomfort
- Reduced Subjective Stress Levels
- Reduced Suicide Attempt
- Reduced Suicide Ideation
- Reduced Suicide-Related Emergency or Hospital Visit
- Reduced Suicide-Related Endpoints
- Reduced Sympathetic Nerve Activity
- Reduced Total Side Effects Incidence
- Reduced Urinary Free Cortisol Levels
- Reduced VIA Positivity
- Stabilized Cortisol Levels
- Stabilized Physiological Stress Markers
- Worsened Depression Score